RALEIGH — Remedy Review, a new media company focused on “separating fact from fiction” in the growing market of cannabidiol (CBD) products, will no longer review or recommend vape products.
The decision was made after a wave of stories about people becoming ill from mislabeled, tainted, or fake vape products, the company announced Wednesday.
Vape products are battery-operated devices that people use to inhale an aerosol, which typically contains nicotine (though not always), flavorings, and other chemicals. They include electronic cigarettes, also known as e-cigarettes, e-vaporizers, or electronic nicotine delivery systems.
“While Remedy Review believes a handful of brands make quality, tested CBD vapes, the products are easily faked and too often end up in the hands of young people,” it said.
E-cigs firm Juul replaces its CEO amid growing vaping crisis
Marc Lewis, executive editor of Remedy Review, added: “We believe oils are the best way to take CBD. While there are vape brands we trust, we don’t like pushing people toward a potentially dangerous category.”
Launched in 2018, Remedy Review is an online site dedicated to publishing “evidence-based articles on the medical, economic, and lifestyle potential of hemp.”
One Better Ventures, which is headed by former Burt’s Bees CEO John Replogle, invested $2 million in the startup. It’s based out of the headquarters at Three Ships, a Raleigh-based digital publisher and customer acquisition company.
Raleigh startup focusing on cannabis-related product information lands $2M